 | • レポートコード：QYR9N7692 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、核酸ベースの治療薬のグローバル市場について調査・分析したレポートで、種類別（アンチセンスおよびアンチ遺伝子、短い阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、その他）、用途別（単遺伝性疾患、多重遺伝性疾患）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・核酸ベースの治療薬の世界市場規模 ・主要企業別市場シェア ・核酸ベースの治療薬の世界市場規模：種類別（アンチセンスおよびアンチ遺伝子、短い阻害配列、遺伝子導入療法、ヌクレオシド類似体、リボザイム、その他） ・核酸ベースの治療薬の世界市場規模：用途別（単遺伝性疾患、多重遺伝性疾患） ・核酸ベースの治療薬のアメリカ市場規模（種類別、用途別） ・核酸ベースの治療薬のヨーロッパ市場規模（種類別、用途別） ・核酸ベースの治療薬の中国市場規模（種類別、用途別） ・核酸ベースの治療薬の日本市場規模（種類別、用途別） ・核酸ベースの治療薬の東南アジア市場規模（種類別、用途別） ・核酸ベースの治療薬のインド市場規模（種類別、用途別） ・核酸ベースの治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・核酸ベースの治療薬の世界市場予測（2019年-2025年） ・核酸ベースの治療薬の地域別市場予測（2019年-2025年） ... |
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.Although most of the nucleic acid-based drugs are in early stages of clinical trials, these classes of compounds have emerged in recent years to yield extremely promising candidates for drug therapy to a wide range of diseases, including cancer, infectious diseases, diabetes, cardiovascular, inflammatory, and neurodegenerative diseases, cystic fibrosis, hemophilia, and other genetic disorders.
In 2018, the global Nucleic Acid-based Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Nucleic Acid-based Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nucleic Acid-based Therapeutics development in United States, Europe and China.
The key players covered in this study
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
Market segment by Type, the product can be split into
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Market segment by Application, split into
Monogenetic Disorders
Multi-Genetic Disorders
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Nucleic Acid-based Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Nucleic Acid-based Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Nucleic Acid-based Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-Sense And Anti-Gene
1.4.3 Short Inhibitory Sequences
1.4.4 Gene Transfer Therapy
1.4.5 Nucleoside Analogs
1.4.6 Ribozymes
1.4.7 Aptamers
1.5 Market by Application
1.5.1 Global Nucleic Acid-based Therapeutics Market Share by Application (2014-2025)
1.5.2 Monogenetic Disorders
1.5.3 Multi-Genetic Disorders
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Nucleic Acid-based Therapeutics Market Size
2.2 Nucleic Acid-based Therapeutics Growth Trends by Regions
2.2.1 Nucleic Acid-based Therapeutics Market Size by Regions (2014-2025)
2.2.2 Nucleic Acid-based Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Nucleic Acid-based Therapeutics Market Size by Manufacturers
3.1.1 Global Nucleic Acid-based Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Nucleic Acid-based Therapeutics Key Players Head office and Area Served
3.3 Key Players Nucleic Acid-based Therapeutics Product/Solution/Service
3.4 Date of Enter into Nucleic Acid-based Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Nucleic Acid-based Therapeutics Market Size by Type (2014-2019)
4.2 Global Nucleic Acid-based Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Nucleic Acid-based Therapeutics Market Size (2014-2019)
5.2 Nucleic Acid-based Therapeutics Key Players in United States
5.3 United States Nucleic Acid-based Therapeutics Market Size by Type
5.4 United States Nucleic Acid-based Therapeutics Market Size by Application
6 Europe
6.1 Europe Nucleic Acid-based Therapeutics Market Size (2014-2019)
6.2 Nucleic Acid-based Therapeutics Key Players in Europe
6.3 Europe Nucleic Acid-based Therapeutics Market Size by Type
6.4 Europe Nucleic Acid-based Therapeutics Market Size by Application
7 China
7.1 China Nucleic Acid-based Therapeutics Market Size (2014-2019)
7.2 Nucleic Acid-based Therapeutics Key Players in China
7.3 China Nucleic Acid-based Therapeutics Market Size by Type
7.4 China Nucleic Acid-based Therapeutics Market Size by Application
8 Japan
8.1 Japan Nucleic Acid-based Therapeutics Market Size (2014-2019)
8.2 Nucleic Acid-based Therapeutics Key Players in Japan
8.3 Japan Nucleic Acid-based Therapeutics Market Size by Type
8.4 Japan Nucleic Acid-based Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Nucleic Acid-based Therapeutics Market Size (2014-2019)
9.2 Nucleic Acid-based Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type
9.4 Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application
10 India
10.1 India Nucleic Acid-based Therapeutics Market Size (2014-2019)
10.2 Nucleic Acid-based Therapeutics Key Players in India
10.3 India Nucleic Acid-based Therapeutics Market Size by Type
10.4 India Nucleic Acid-based Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Nucleic Acid-based Therapeutics Market Size (2014-2019)
11.2 Nucleic Acid-based Therapeutics Key Players in Central & South America
11.3 Central & South America Nucleic Acid-based Therapeutics Market Size by Type
11.4 Central & South America Nucleic Acid-based Therapeutics Market Size by Application
12 International Players Profiles
12.1 Wave Life Sciences
12.1.1 Wave Life Sciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nucleic Acid-based Therapeutics Introduction
12.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.1.5 Wave Life Sciences Recent Development
12.2 Imugene
12.2.1 Imugene Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nucleic Acid-based Therapeutics Introduction
12.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.2.5 Imugene Recent Development
12.3 Caperna
12.3.1 Caperna Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nucleic Acid-based Therapeutics Introduction
12.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.3.5 Caperna Recent Development
12.4 Phylogica
12.4.1 Phylogica Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nucleic Acid-based Therapeutics Introduction
12.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.4.5 Phylogica Recent Development
12.5 Protagonist Therapeutics
12.5.1 Protagonist Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nucleic Acid-based Therapeutics Introduction
12.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.5.5 Protagonist Therapeutics Recent Development
12.6 Benitec Biopharma
12.6.1 Benitec Biopharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nucleic Acid-based Therapeutics Introduction
12.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.6.5 Benitec Biopharma Recent Development
12.7 EGEN
12.7.1 EGEN Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nucleic Acid-based Therapeutics Introduction
12.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.7.5 EGEN Recent Development
12.8 BioMedica
12.8.1 BioMedica Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nucleic Acid-based Therapeutics Introduction
12.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.8.5 BioMedica Recent Development
12.9 Transgene
12.9.1 Transgene Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nucleic Acid-based Therapeutics Introduction
12.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.9.5 Transgene Recent Development
12.10 Copernicus Therapeutics
12.10.1 Copernicus Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nucleic Acid-based Therapeutics Introduction
12.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)
12.10.5 Copernicus Therapeutics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Nucleic Acid-based Therapeutics Key Market Segments
Table Key Players Nucleic Acid-based Therapeutics Covered
Table Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type 2014-2025
Figure Anti-Sense And Anti-Gene Figures
Table Key Players of Anti-Sense And Anti-Gene
Figure Short Inhibitory Sequences Figures
Table Key Players of Short Inhibitory Sequences
Figure Gene Transfer Therapy Figures
Table Key Players of Gene Transfer Therapy
Figure Nucleoside Analogs Figures
Table Key Players of Nucleoside Analogs
Figure Ribozymes Figures
Table Key Players of Ribozymes
Figure Aptamers Figures
Table Key Players of Aptamers
Table Global Nucleic Acid-based Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Monogenetic Disorders Case Studies
Figure Multi-Genetic Disorders Case Studies
Figure Nucleic Acid-based Therapeutics Report Years Considered
Table Global Nucleic Acid-based Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Share by Regions 2014-2019
Figure Global Nucleic Acid-based Therapeutics Market Share by Regions 2014-2019
Figure Global Nucleic Acid-based Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Nucleic Acid-based Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Nucleic Acid-based Therapeutics Market Share by Manufacturers in 2018
Table Global Nucleic Acid-based Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nucleic Acid-based Therapeutics Product/Solution/Service
Table Date of Enter into Nucleic Acid-based Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size Share by Type (2014-2019)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Nucleic Acid-based Therapeutics Market Size Share by Application (2014-2019)
Figure Global Nucleic Acid-based Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Nucleic Acid-based Therapeutics Revenue Market Share by Application in 2018
Figure United States Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table United States Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table United States Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure Europe Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table Europe Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table Europe Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure China Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table China Nucleic Acid-based Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table China Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure Japan Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table Japan Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table Japan Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure India Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table India Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table India Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Nucleic Acid-based Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nucleic Acid-based Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nucleic Acid-based Therapeutics Market Share (2018-2019)
Table Central & South America Nucleic Acid-based Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Nucleic Acid-based Therapeutics Market Share by Type (2014-2019)
Table Central & South America Nucleic Acid-based Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Nucleic Acid-based Therapeutics Market Share by Application (2014-2019)
Table Wave Life Sciences Company Details
Table Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2014-2019) (Million US$)
Figure Wave Life Sciences Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Wave Life Sciences Recent Development
Table Imugene Company Details
Table Imugene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Imugene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Imugene Recent Development
Table Caperna Company Details
Table Caperna Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Caperna Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Caperna Recent Development
Table Phylogica Company Details
Table Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Phylogica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Phylogica Recent Development
Table Protagonist Therapeutics Company Details
Table Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Protagonist Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Protagonist Therapeutics Recent Development
Table Benitec Biopharma Company Details
Table Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Benitec Biopharma Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Benitec Biopharma Recent Development
Table EGEN Company Details
Table EGEN Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure EGEN Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table EGEN Recent Development
Table BioMedica Company Details
Table BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure BioMedica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table BioMedica Recent Development
Table Transgene Company Details
Table Transgene Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Transgene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Transgene Recent Development
Table Copernicus Therapeutics Company Details
Table Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2014-2019)(Million US$)
Figure Copernicus Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2014-2019)
Table Copernicus Therapeutics Recent Development
Table Global Nucleic Acid-based Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Nucleic Acid-based Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Nucleic Acid-based Therapeutics Market Size Share by Regions in 2025
Figure United States Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nucleic Acid-based Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Nucleic Acid-based Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size by Product (2019-2025)
Figure Global Nucleic Acid-based Therapeutics Market Size by Product in 2025
Table Global Nucleic Acid-based Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Nucleic Acid-based Therapeutics Market Size by Application (2019-2025)
Figure Global Nucleic Acid-based Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界のペプチドベースの胃腸障害治療薬市場：市場規模・現状・予測 Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.In 2018, the global Peptide Based Gastrointestinal Disorders Ther…- 世界のペプチドベースの代謝障害治療薬市場：市場規模・現状・予測 A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…
- 世界の遺伝子移植市場：市場規模・現状・予測 Gene Transplant is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV…
- 世界のRNAベースの治療薬とワクチン市場：市場規模・現状・予測 RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.RNA-based biopharmaceuticals are a relatively new c…
- 世界のペプチドベースのがん治療薬市場：市場規模・現状・予測 Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer.In 2018, the global Peptide Based Cancer Therapeutics market size was…